GB202115824D0 - Antibodies - Google Patents

Antibodies

Info

Publication number
GB202115824D0
GB202115824D0 GBGB2115824.1A GB202115824A GB202115824D0 GB 202115824 D0 GB202115824 D0 GB 202115824D0 GB 202115824 A GB202115824 A GB 202115824A GB 202115824 D0 GB202115824 D0 GB 202115824D0
Authority
GB
United Kingdom
Prior art keywords
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2115824.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rq Biotechnology Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GBGB2115824.1A priority Critical patent/GB202115824D0/en
Publication of GB202115824D0 publication Critical patent/GB202115824D0/en
Priority to PCT/GB2022/050306 priority patent/WO2022167815A1/en
Priority to JP2023547271A priority patent/JP2024509055A/en
Priority to JP2023547270A priority patent/JP2024509054A/en
Priority to US18/264,241 priority patent/US20240036054A1/en
Priority to PCT/GB2022/050307 priority patent/WO2022167816A2/en
Priority to EP22704567.1A priority patent/EP4288152A2/en
Priority to EP22705090.3A priority patent/EP4288153A1/en
Priority to US18/264,226 priority patent/US20240043507A1/en
Ceased legal-status Critical Current

Links

GBGB2115824.1A 2021-02-04 2021-11-03 Antibodies Ceased GB202115824D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB2115824.1A GB202115824D0 (en) 2021-11-03 2021-11-03 Antibodies
PCT/GB2022/050306 WO2022167815A1 (en) 2021-02-04 2022-02-04 Antibodies
JP2023547271A JP2024509055A (en) 2021-02-04 2022-02-04 antibody
JP2023547270A JP2024509054A (en) 2021-02-04 2022-02-04 antibody
US18/264,241 US20240036054A1 (en) 2021-02-04 2022-02-04 Antibodies
PCT/GB2022/050307 WO2022167816A2 (en) 2021-02-04 2022-02-04 Antibodies
EP22704567.1A EP4288152A2 (en) 2021-02-04 2022-02-04 Antibodies
EP22705090.3A EP4288153A1 (en) 2021-02-04 2022-02-04 Antibodies
US18/264,226 US20240043507A1 (en) 2021-02-04 2022-02-04 Antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2115824.1A GB202115824D0 (en) 2021-11-03 2021-11-03 Antibodies

Publications (1)

Publication Number Publication Date
GB202115824D0 true GB202115824D0 (en) 2021-12-15

Family

ID=78828487

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2115824.1A Ceased GB202115824D0 (en) 2021-02-04 2021-11-03 Antibodies

Country Status (1)

Country Link
GB (1) GB202115824D0 (en)

Similar Documents

Publication Publication Date Title
SI3872091T1 (en) Antibodies against sars-cov-2
IL289112A (en) Anti-tigit antibodies
IL291068A (en) Anti-cd73 antibodies
IL284584A (en) Anti-tigit antibodies
GB201905150D0 (en) Ant-ige antibodies
GB201917480D0 (en) Antibodies
IL308741A (en) Anti-sirp-alpha antibodies
GB201900732D0 (en) Antibodies
IL300142A (en) ANTI-IL13Ralpha2 ANTIBODIES
GB202105110D0 (en) Anti-CD73 antibodies
IL289160A (en) Anti-angpt2 antibodies
GB202014851D0 (en) SARS-COV-2 antibodies
GB202015115D0 (en) ZIP12 Antibody
IL311043A (en) Anti-il-11rα antibodies
IL310245A (en) Anti-hla-g antibodies
GB202208773D0 (en) Anti-SARS2-S antibodies
IL308782A (en) Antibodies
IL308100A (en) Antibodies
IL307175A (en) Il-38-specific antibodies
GB202116709D0 (en) Antibodies
GB202115824D0 (en) Antibodies
GB202112297D0 (en) Antibodies
IL299767A (en) Anti-αlpha-4-βeta-7 antibodies
GB202107517D0 (en) Antibodies
GB202104128D0 (en) Antibodies

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: RQ BIOTECHNOLOGY LTD

Free format text: FORMER OWNER: OXFORD UNIVERSITY INNOVATION LIMITED

AT Applications terminated before publication under section 16(1)